Carbidopa And Levodopa
Product Images NDC 0228-2538

8 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 0228-2538). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

67944b5f-figure-01 (Image 1)

67944b5f-figure-01 (Image 1)
Chemical structure of the active ingredient in Carbidopa and levodopa, showing the molecular formula with hydroxyl groups, methyl group, carboxyl group, hydrazine moiety, and water of hydration.*
FDA Label Image

67944b5f-figure-02 (Image 2)

67944b5f-figure-02 (Image 2)
Chemical structure of carbidopa and levodopa showing the molecular arrangement with hydroxyl groups, an amino group, and a carboxyl group attached to a benzene ring.*
FDA Label Image

67944b5f-figure-03 (Image 3)

67944b5f-figure-03 (Image 3)
Carbidopa and levodopa immediate release tablets packaging label by Actavis Pharma, Inc. The label shows the product name and indicates it is for oral use, with directions to take by mouth. The label includes storage information and barcode with numeric codes.*
FDA Label Image

67944b5f-figure-04 (Image 4)

67944b5f-figure-04 (Image 4)
The image shows a vial label for Carbidopa and levodopa injection, displaying product name and concentration details. The label includes text sections with directions and warnings, the Actavis Pharma, Inc. labeler information, and barcodes. It is designed as a sterile single-use injectable solution.*
FDA Label Image

67944b5f-figure-05 (Image 5)

67944b5f-figure-05 (Image 5)
Carbidopa and levodopa tablet bottle label from Actavis Pharma, Inc. The label has a white background with blue and orange design elements, displaying the product name prominently. It includes a barcode and U.S. distributor information but does not show strength or quantity details.*
FDA Label Image

1 (Image 6)

1 (Image 6)
Label for Carbidopa and Levodopa Tablets, USP 10 mg/100 mg by Actavis Pharma, Inc., containing 100 tablets. The label includes dosing information, storage instructions, and manufacturer details for Teva Pharmaceuticals USA, Inc. It features the product name, NDC code, barcode, and a note that it is Rx only.*
FDA Label Image

1 (Image 7)

1 (Image 7)
Label for Carbidopa and Levodopa Tablets, USP 25 mg/100 mg from Actavis Pharma, Inc. The label indicates the package contains 100 tablets for prescription use only. It includes dosage information, storage instructions, manufacturer details from Teva Pharmaceuticals USA, Inc., and a barcode with NDC 0228-2539-10.*
FDA Label Image

1 (Image 8)

1 (Image 8)
Label for Carbidopa and Levodopa Tablets, USP 25 mg/250 mg by Actavis Pharma, Inc., containing 100 tablets. The label includes dosage composition, storage instructions, and manufacturer information. Features a barcode and serialization coding area on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.